Brief: PCI Biotech Q3 Operating Loss Narrows To NOK 10.9 Million
Nov 23 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* REG-PCI BIOTECH INTERIM Q3 2022 REPORT
* Q3 OPERATING LOSS NOK 10.9 MILLION VERSUS LOSS NOK 22.5
MILLION
YEAR AGO
Source text for Eikon: ID:nGNE93DKkz
Further company coverage: PCIB.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process